Difficulty: Medium
Average Score: 93%
Practice
Which of the following drugs is an agent of substitution therapy?
Correct answer
B
Rationale
In the context of cardiovascular drugs and substitution therapy, the correct answer is option B) Hydrochloric acid. Substitution therapy involves replacing a deficient or missing substance in the body with an external source. In this case, hydrochloric acid can be used as a substitution therapy for individuals with certain medical conditions that result in low stomach acid production.
Option A) Gastrin is a hormone that stimulates the secretion of gastric acid, so it is not a form of substitution therapy but rather a regulatory hormone in the stomach.
Option C) Histamine is a compound involved in allergic reactions and inflammatory responses, not used for substitution therapy in cardiovascular conditions.
Option D) Carbonate mineral waters do not directly replace a deficient substance in the body, so it is not a form of substitution therapy for cardiovascular conditions.
Understanding the concept of substitution therapy is crucial in pharmacology, as it helps healthcare providers choose the appropriate treatment to address specific deficiencies or imbalances in the body. In the case of cardiovascular drugs, selecting the correct therapy tailored to the patient's needs is essential for optimal outcomes and patient safety.
Option A) Gastrin is a hormone that stimulates the secretion of gastric acid, so it is not a form of substitution therapy but rather a regulatory hormone in the stomach.
Option C) Histamine is a compound involved in allergic reactions and inflammatory responses, not used for substitution therapy in cardiovascular conditions.
Option D) Carbonate mineral waters do not directly replace a deficient substance in the body, so it is not a form of substitution therapy for cardiovascular conditions.
Understanding the concept of substitution therapy is crucial in pharmacology, as it helps healthcare providers choose the appropriate treatment to address specific deficiencies or imbalances in the body. In the case of cardiovascular drugs, selecting the correct therapy tailored to the patient's needs is essential for optimal outcomes and patient safety.